Literature DB >> 7435120

Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients.

J G Klijn, S W Lamberts, F H de Jong, K J van Dongen, J C Birkenhäger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7435120     DOI： 10.1530/acta.0.0950289

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  11 in total

1.  Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas.

Authors:  M Losa; R L Barzaghi; P Mortini; A Franzin; F Mangili; M R Terreni; M Giovanelli
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 3.  A risk-benefit assessment of octreotide in the treatment of acromegaly.

Authors:  A J van der Lely; W W de Herder; S W Lamberts
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

4.  Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy.

Authors:  E Ghigo; B M K Biller; A Colao; I A Kourides; N Rajicic; R K Hutson; L De Marinis; A Klibanski
Journal:  J Endocrinol Invest       Date:  2009-12-04       Impact factor: 4.256

5.  Absence of immunostaining for growth hormone in a subset of patients with acromegaly.

Authors:  Jason L Schroeder; Alejandro M Spiotta; Maria Fleseriu; Richard A Prayson; Amir H Hamrahian; Robert J Weil
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

6.  Hypothalamic-pituitary-thyroid axis in acromegaly.

Authors:  E Carmina; F Rosato; S Pirronello; A Jannì
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

7.  Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.

Authors:  Tirissa J Reid; Kalmon D Post; Jeffrey N Bruce; M Nabi Kanibir; Carlos M Reyes-Vidal; Pamela U Freda
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-16       Impact factor: 3.478

8.  Grading of pituitary adenomas in acromegaly. Comparison of light microscopical, immunocytochemical, and clinical data.

Authors:  M Riedel; W Saeger; D K Lüdecke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

9.  Role of cell and explant culture in the diagnosis and characterization of human pituitary tumours.

Authors:  E F Adams; K Mashiter
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

10.  Acromegaly: an epidemiological study.

Authors:  J Etxabe; S Gaztambide; P Latorre; J A Vazquez
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.